Skip to main content
CRDF logo
CRDF
(NASDAQ)
Cardiff Oncology, Inc.
$1.09-- (--)
Loading... - Market loading

Cardiff Oncology (CRDF) Stock Price & Financial Analysis

Cardiff Oncology Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$1.07 - $1.10
52-Week High$3.31
52-Week Low$0.76
Open$1.08
Volume437.28K
Average Volume (3M)750.67K
Market Cap74.50M
Shares Outstanding68.35M
Price to Sales (P/S)141.91
Price to Book (P/B)2.15
EV/EBITDA-1.49
Revenue (TTM)525.00K
Net Income (TTM)-44.76M
Free Cash Flow (TTM)-37.46M
EPS (TTM)$-0.67
Profit Margin-8526.10%
Operating Margin-9033.90%
Return on Equity (ROE)-128.96%
Debt to Equity0.02
50-Day MA$1.02
200-Day MA$1.72
52-Week Change-49.77%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Cardiff Oncology

What is the current stock price for CRDF?

As of the latest trading session, CRDF stock trades at $1.09. The 52-week range is $0.76–$3.31, with a day range of $1.06–$1.10.

What is the P/E ratio for CRDF?

The P/E ratio (Price-to-Earnings) for CRDF is shown in the Key Statistics section. This valuation metric helps compare Cardiff Oncology, Inc. to industry peers.

Does CRDF pay dividends?

Cardiff Oncology does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CRDF?

Analyst ratings and recommendations for CRDF are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of CRDF?

Cardiff Oncology's market capitalization is $74.5M, classifying it as a micro-cap company. Cardiff Oncology operates in the Healthcare sector within the Biotechnology industry.